Research Article
The Apolipoprotein B/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity
Table 1
Baseline characteristics of study participants (
).
| | | Median (25%; 75%) | Min–Max |
| | Age, years | 36.0 (29.0; 45.0) | 20–59 | | Body mass index, kg/m2 | 24.8 (22.6; 26.5) | 18.0–29.9 | | TC, mmol/L | 4.13 (3.58; 4.64) | 2.73–5.15 | | TG, mmol/L | 1.11 (0.87; 1.38) | 0.56–1.70 | | HDL-C, mmol/L | 1.40 (1.21; 1.56) | 1.00–1.99 | | LDL-C, mmol/L | 2.21 (1.66; 2.69) | 0.42–3.68 | | Non-HDL-C, mmol/L | 2.74 (2.14; 3.26) | 1.01–4.11 | | TC/HDL-C | 2.93 (2.48; 3.45) | 1.57–4.99 | | ApoA-I, mg/dL | 149.8 (100.8; 180.0) | 50.0–300.0 | | ApoB, mg/dL | 78.0 (56.1; 102.0) | 30.0–218.0 | | ApoB/apoA-I | 0.52 (0.42; 0.78) | 0.19–2.60 | | ApoE, mg/dL | 2.61 (1.91; 3.46) | 0.48–5.54 | | LDL-C/apoB | 1.06 (0.73; 1.46) | 0.20–2.48 | | AIP | −0.09 (−0.22; −0.01) | −0.45–0.22 |
|
|
Values are presented as the median, interquartile range, minimum, and maximum.
|
